Discover Better Body Composition With Green Light!

Investigation into Green Light Therapy study using EmeraldLED for 15-minute sessions, twice a week, to support positive changes in body composition.

Study Overview

• Status: Recruiting
• Conditions: Body Composition
• Intervention / Treatment: Device: EmeraldLED

Detailed Description

This remotely administered decentralized trial is designed to rigorously explore the efficacy of green light therapy in influencing body composition and overall well-being. Under the leadership of Ryan, CEO of beem® Light Sauna, this study leverages the expansive network of over 50 wellness franchise locations across the United States, along with 30 years of fitness and wellness industry experience, to investigate the science-backed potential of green light therapy. Amidst the widespread speculation and anecdotal evidence circulating on social media, investigators seek to provide concrete, personalized data to participants, thereby empowering them with the knowledge to make informed decisions about their health and wellness strategies.

The core objective of this online study is to empower participants by providing a detailed analysis of how exposure to green light impacts their weight management journey and overall sense of well-being. By participating in this study, individuals will receive tailored feedback on their body composition changes and psychological well-being, offering a unique opportunity to understand the potential benefits of green light therapy on a personal level.

Participants in this remotely conducted trial will engage with state-of-the-art green light therapy sessions from the comfort of their chosen environment, ensuring a broad and inclusive participant base without geographic limitations. This approach not only facilitates a more diverse data set but also aligns with our commitment to making health innovations accessible to a wider audience.

The significance of this study cannot be overstated, as it aims to demystify the claims surrounding green light therapy and its effects on weight management and mental health. By contributing to this pioneering research, participants will be at the forefront of a potential paradigm shift in the approach to wellness and body composition optimization. While acknowledging the limitations of this study and the need for further extensive trials, the insights gained here will be invaluable in guiding future health innovations and strategies, marking a significant step towards a healthier, more informed society.

• Study Type: Interventional
• Enrollment (Estimated): 100
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Matthew Amsden; Phone Number: 646-679-2479; Email: help@efforia.com

Study Locations

• United States
  • New York
    • New York, New York, United States, 10003
      • Recruiting
      • Efforia
      • Contact: Matthew Amsden; Phone Number: (646) 679-2479; Email: help@efforia.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Can read and understand English.
• US resident.
• Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

-individuals with eye conditions

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Single arm where participants act as their own control

Device: EmeraldLED; This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm². The green light EmeraldLED therapy provided in this study is set at 525 nm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Body Image and Self-Perception Survey	This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.	Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33)
Body Composition Measurement Form	The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.	Change from baseline (Day 1-3) in body composition measurements at 4 weeks after the start of the intervention (Day 27-33)
Quality of Life and Health Survey	This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.	Change from baseline (Day 1-3) in quality of life and health perceptions at 4 weeks after the start of the intervention (Day 27-33)

Collaborators and Investigators

• Sponsor: Efforia, Inc

Publications and helpful links

Helpful Links

• Additional information and join instructions on Efforia

Study record dates

Study Major Dates

• Study Start (Actual): August 15, 2025
• Primary Completion (Estimated): August 15, 2026
• Study Completion (Estimated): August 15, 2026

Study Registration Dates

• First Submitted: December 5, 2025
• First Submitted That Met QC Criteria: December 5, 2025
• First Posted (Estimated): December 15, 2025

Study Record Updates

• Last Update Posted (Actual): December 23, 2025
• Last Update Submitted That Met QC Criteria: December 19, 2025
• Last Verified: December 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: 43172

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes
• product manufactured in and exported from the U.S.: No